SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc., (Nasdaq:KITE) today announced that management will present at the Canaccord Genuity 36th Annual Growth Conference.
Event: Canaccord Genuity 36th Annual Growth ConferenceDate:Wednesday, August 10, 2016Time:2:00 PM Eastern TimeLocation:Boston, MA
A live audio webcast will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of the webcast will be available on the website for approximately 30 days.
About Kite Pharma
Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160803006536/en/
Kite PharmaGreg MannVP, Investor Relationsgmann@kitepharma.comorFor Media:inVentiv HealthDavid Polk, 310-309-1029david.polk@inventivhealth.com
Source: Kite Pharma, Inc.
News Provided by Acquire Media
